To investigate whether there is any correlation between MASLD and intestinal Pgc1α modulation, we analysed the mRNA expression of Pgc1α and its target genes in mice after the induction of liver steatosis and MASH. This evidence concerns the gene PPARGC1A and fatty liver disease.